
What Each of the Six Placental Regions Contributes to Ultra RSF
One organ, six anatomically distinct regions, six different jobs across a pregnancy — and therefore six different sets of instructions to contribute.
How Ultra RSF is made, step by step: six-region sourcing, GMP washing and disinfection, acellular purification, pathogen screening and freeze-drying.

Patients ask what a treatment does far more often than they ask how it was made. That is understandable, and in regenerative medicine it is also the wrong way round. What a preparation contains, and what was done to it before it reached the vial, is the part that can actually be checked.
Ultra RSF (Regenerative Signaling Factors) passes through five processing steps between placental tissue and a sealed vial of freeze-dried powder. Each step removes something, verifies something, or preserves something. Here they are in order, followed by the more useful question of why each one exists.
Factors are drawn from six distinct regions of the placenta (decidua, villous placenta, umbilical cord blood, Wharton's jelly, amnion and chorion) rather than from a single-region extract.
The material is thoroughly washed and disinfected under GMP conditions before any further processing takes place.
Purification removes all living cells. What remains is fully acellular and free of DNA and RNA material.
Pathogen testing follows 21 CFR 1271.55. Composition is then characterised by next-generation sequencing and mass spectrometry.
The concentrate is freeze-dried for stability and consistent batch-to-batch handling, then reconstituted with 1 mL of sterile water at the point of use.
Sourcing is a decision made before any processing happens, and it caps everything that follows. A preparation cannot contain signals that were not in the starting material, so the choice of tissue sets the ceiling on the range of proteins the finished concentrate can carry.
Most products in this category start from one tissue. Ultra RSF starts from six, each of which does a different job across a pregnancy and therefore carries a different signalling vocabulary. What each region contributes is set out in the six-region breakdown. Worth restating: this is a statement about the breadth of the input, not a claim that the outcome is better.
GMP stands for Good Manufacturing Practice — the framework governing how a medical product is produced, documented and controlled. Washing and disinfection happen under those conditions, and they happen before anything else is done to the material.
The order is not arbitrary. Everything present in the starting material gets carried forward into whatever is made from it, and a purification step designed to concentrate proteins will concentrate whatever else is sitting alongside them. Removing what should not be there is more complete, and considerably more honest, at the beginning than at the end.
The third step is the one that decides what this product is. Purification removes all living cells, and the material that comes out the other side is free of DNA and RNA. Everything that distinguishes Ultra RSF from a stem-cell preparation follows from this single step.
Removing the cells removes the reasons live-cell preparations are difficult. There is no donor cell line to vary between batches, no cold chain protecting something fragile, nothing capable of engrafting or dividing. What is left is the secreted vocabulary on its own: more than 300 proteins and growth factors, and no messenger to carry them.
Step four is really three separate examinations, answering different questions at different stages. They tend to get compressed into the single word "tested" in marketing material, which loses the useful detail.
Characterisation is also what makes batch-to-batch consistency a verifiable property rather than a promise. A preparation grown from a cultured cell line varies with how that culture behaved; one characterised by sequencing and mass spectrometry can be compared against the last batch on paper. That comparison is set out alongside the alternatives in stem cells vs. exosomes vs. RSF.
Lyophilisation removes water from the concentrate under vacuum, leaving a dry powder that is stable at room temperature. It is an unglamorous step and it changes almost everything about how the product can be used.
A freeze-dried vial does not need a cold chain, which is why the material can be shipped, stored and given somewhere other than a laboratory-adjacent clinic — including a patient's own home, as described in in-home regenerative care. Reconstitution with 1 mL of sterile water happens immediately before administration, so the concentrate spends almost no time in solution before it is given.
Placental material from six regions is washed and disinfected under GMP conditions, purified until it is fully acellular and free of DNA and RNA, screened for pathogens under 21 CFR 1271.55, characterised by next-generation sequencing and mass spectrometry, then freeze-dried for storage.
Lyophilisation is freeze-drying: water is removed so that the remaining material is stable at room temperature. Ultra RSF is reconstituted with 1 mL of sterile water immediately before it is administered.
No. Because it is freeze-dried it does not require a cold chain, which is what allows it to be shipped and stored without the handling constraints a live-cell preparation carries.
It is the federal standard cited for screening donor material used in human tissue products. Pathogen testing for Ultra RSF follows it, and the screening is applied before processing begins.
No. Sourcing, purification, screening and characterisation describe what is in the vial and how it was handled. They are not evidence of clinical benefit, which is a separate question requiring a different kind of study.
This article is general health information, not medical advice, and does not create a physician–patient relationship. It describes mechanisms reported in the literature rather than guaranteed outcomes; individual response varies. Regen MDs provides you an alternative to your current care, and is complementary to your guideline-based medical care. Ultra RSF (Regenerative Signaling Factors) is not a stem-cell therapy. Talk to a licensed clinician before starting, stopping, or changing any treatment.

One organ, six anatomically distinct regions, six different jobs across a pregnancy — and therefore six different sets of instructions to contribute.

The reason so much regenerative research points away from the cells themselves, and what a physician is actually giving when the vial says signaling factors.

Route is not an administrative detail. It decides where a signalling preparation arrives first, and it is chosen from an evaluation rather than from a menu.
Thirty minutes with one of our physicians — no cost, no obligation — to review your history and set out the options honestly.